Commentary : Hypothesis Focused Ultrasound and NXY-059 in Experimental Cerebral Ischemia: A New Therapeutic Opportunity?

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|9|1010-1013

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.9, 2016-11, pp. : 1010-1013

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059

By Green A.R. Ashwood T. Odergren T. Jackson D.M.

Pharmacology and Therapeutics, Vol. 100, Iss. 3, 2003-12 ,pp. : 195-214

Elsevier

Access to resources Recommend Favorite

NXY 059: CPI 22, NXY 059G

By Limited A.I.

Drugs in R&D, Vol. 4, Iss. 4, 2003-01 ,pp. : 254-257

Adis International

Access to resources Recommend Favorite

By Kirk R. Maples

CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. : 1071-1084

Adis International

Access to resources Recommend Favorite

Commentary: Death Associated Protein Kinase 1: A Perp in Cerebral Ischemia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 8, 2016-09 ,pp. : 874-877

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding hypoxia signalling in cells – a new therapeutic opportunity?

By Ratcliffe Peter J

Clinical Medicine, Vol. 6, Iss. 6, 2006-12 ,pp. : 573-578

Royal College Of Physicians

Access to resources Recommend Favorite